Read More Pharma Industry News Hemab Therapeutics raises $135m for prophylactic treatments for bleeding and thrombotic disorders Hemab Therapeutics, a clinical-stage biotechnology company, has raised $135 million in a Series B financing round for advancing… byRaghuram KadariFebruary 22, 2023